Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

4.0K
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
4.0K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

541
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
541
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

374
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
374
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

445
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
445
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

601
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
601
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

3.3K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Suicidal ideation in patients with skin conditions: A multicentre European study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

"White seborrheic keratosis": a misunderstood entity in skin of color.

Annales de dermatologie et de venereologie·2026
Same author

Erythrosis pigmentosa mediofacialis (Brocq): A hypothesis on the involvement of Demodex folliculorum.

Annales de dermatologie et de venereologie·2025
Same author

Strong propensity to accept a diagnosis via tele-expertise in dermatology: A nationwide analysis.

Annales de dermatologie et de venereologie·2025
Same author

Two cases of bullous haemorrhagic dermatosis (BHD) induced by enoxaparin.

Annales de dermatologie et de venereologie·2024
Same author

Treatment of facial and axillary lupus miliaris with adalimumab.

Annales de dermatologie et de venereologie·2024
Same journal

Comment on 'Incidence and Mortality of Mucous Membrane Pemphigoid in France': reply from authors.

The British journal of dermatology·2026
Same journal

Randomised Controlled Feasibility Trial of an Intervention to Reduce Infant Bathing.

The British journal of dermatology·2026
Same journal

Dupilumab treatment restores skin nerve fibre density in patients with moderate-to-severe atopic dermatitis: results from DIFFERENSTAD, an open-label exploratory study.

The British journal of dermatology·2026
Same journal

Mee's Lines.

The British journal of dermatology·2026
Same journal

Geographic diversity in top dermatology journal editorial boards.

The British journal of dermatology·2026
Same journal

Molecular heterogeneity in systemic sclerosis skin: insights from single-cell and spatial omics, and implications for disease stratification and cutaneous assessment.

The British journal of dermatology·2026
See all related articles

Related Experiment Video

Updated: Mar 11, 2026

Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases
07:36

Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases

Published on: July 3, 2025

832

Rosacea treatment update: recommendations from the global ROSacea COnsensus (ROSCO) panel.

M Schaller1, L M C Almeida2, A Bewley3,4

  • 1Department of Dermatology, Universitatsklinikum Tubingen, Tubingen, Baden-Württemberg, Germany.

The British Journal of Dermatology
|November 19, 2016
PubMed
Summary
This summary is machine-generated.

This study proposes a new approach to rosacea treatment, focusing on clinical presentation (phenotypes) rather than subtypes. Experts reached consensus on phenotype-based treatments to improve patient outcomes for this common skin condition.

More Related Videos

Author Spotlight: Advancing Facial Rejuvenation Therapy with Post-Laser Salicylic Acid Application
03:47

Author Spotlight: Advancing Facial Rejuvenation Therapy with Post-Laser Salicylic Acid Application

Published on: September 27, 2024

1.6K
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.6K

Related Experiment Videos

Last Updated: Mar 11, 2026

Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases
07:36

Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases

Published on: July 3, 2025

832
Author Spotlight: Advancing Facial Rejuvenation Therapy with Post-Laser Salicylic Acid Application
03:47

Author Spotlight: Advancing Facial Rejuvenation Therapy with Post-Laser Salicylic Acid Application

Published on: September 27, 2024

1.6K
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.6K

Area of Science:

  • Dermatology and clinical research.
  • Investigating novel treatment paradigms for chronic inflammatory skin conditions.

Background:

  • Current rosacea subtype classification inadequately addresses diverse patient phenotypes.
  • This limitation impacts effective patient management and treatment outcomes.
  • The ROSacea COnsensus panel was formed to refine rosacea treatment strategies.

Framework:

  • A modified Delphi approach was employed, involving 17 dermatologists and 3 ophthalmologists.
  • Consensus (≥75% agreement) was reached on critical aspects of rosacea management.
  • Voting was conducted electronically and blinded to ensure objectivity.

Implementation:

  • Phenotype-based treatment guidelines were established for rosacea signs and symptoms.
  • First-line treatments were identified for erythema, papules/pustules, telangiectasia, and phyma.
  • General skincare measures form the foundation of treatment, with options for multiple simultaneous treatments and adjustments if initial therapy is inadequate.

Implications:

  • Rosacea diagnosis and treatment should prioritize clinical presentation (phenotypes).
  • This consensus supports a more personalized and effective approach to managing rosacea.
  • Ophthalmological referral is recommended for significant ocular rosacea features, with specific management strategies including lid hygiene and artificial tears.